Skip to main content
SpringerLink
Log in

Epidemiology of Group B Coxsackieviruses

  • Chapter
Coxsackieviruses

Part of the book series: Infectious Agents and Pathogenesis ((IAPA))

Abstract

The Coxsackie B viruses (CVB) are members of the genus Enterovirus and share many properties with other members of this group. There are several excellent reviews covering the basic epidemiology and clinical characteristics of enteroviruses and their infections1–4; this material is not repeated in detail, except as it relates to recent studies. Most of the conclusions concerning enteroviruses in general are directly applicable to CVB, including seasonality; geographic, age, and sex distribution; incidence and prevalence; transmission; and most clinical syndromes.

This chapter has been prepared as a work of the United States Government and is not protected under Title 17 of the United States Code.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Melnick, J. L., 1982, Enteroviruses, in: Viral Infections of Humans, Epidemiology and Control (A. S. Evans, ed.), pp. 187–251, Plenum, New York.

    Google Scholar 

  2. Moore, M., and Morens, D. M., 1984, Enteroviruses, including polioviruses, in: Textbook of Human Virology (R. B. Belshe, ed.), pp. 407–483, PSG, Littleton, Massachusetts.

    Google Scholar 

  3. Melnick, J. L., 1985, Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses, in: Virology (B. N. Fields, D. M. Knipe, R. M. Chanock, J. L. Melnick, B. Roizman, and R. E. Shope, eds.), pp. 739–794, Raven, New York.

    Google Scholar 

  4. Modlin, J. F., 1985, Coxsackievirus and echovirus, in: Pńnciples and Practices of Infectious Diseases (G. L. Mandell, R. G. Douglas, Jr., and J. E. Bennett, eds.), pp. 814–825, Wiley, New York.

    Google Scholar 

  5. Strikas, R. A., Anderson, L. J., and Parker, R. A., 1986, Temporal and geographic patterns of isolates of nonpolio enterovirus in the United States, 1970–1983,J. Infect. Dis. 153:346–351.

    CAS  Google Scholar 

  6. Bell, E. J., and McCartney, R. A., 1984, A study of Coxsackie B virus infections, 1972–1983, J. Hyg. (Lond.) 93:197–204.

    CAS  Google Scholar 

  7. Schoub, B. D., Johnson, S., McAnerney, J. M., Dos Santos, I. L., and Klaassen, K. I., 1985, Epidemic Coxsackie B virus infection in Johannesburg, South Africa, J. Hyg. (Lond.) 95:447–455.

    CAS  Google Scholar 

  8. Centers for Disease Control, 1970, Neurotropic Viral Diseases Surveillance, Enterovirus Infections, Annual Summary, 1969, Centers for Disease Control, Atlanta, Georgia.

    Google Scholar 

  9. Centers for Disease Control, 1970, Neurotropic Viral Diseases Surveillance, Enterovirus Infections, January—September, 1970, Centers for Disease Control, Atlanta, Georgia.

    Google Scholar 

  10. Centers for Disease Control, 1971, Neurotropic Diseases Surveillance, Enterovirus Infections, Annual Summary, 1970, Centers for Disease Control, Atlanta, Georgia.

    Google Scholar 

  11. Centers for Disease Control, 1977, Enteńc and Neurotropic Diseases Surveillance, Enterovirus Surveillance, 1971–1975, Centers for Disease Control, Atlanta, Georgia.

    Google Scholar 

  12. Centers for Disease Control, 1981, Enterovirus Surveillance, Summary 1970–1979, Centers for Disease Control, Atlanta, Georgia.

    Google Scholar 

  13. Morens, D. M., Zweighaft, R. M., and Bryan, J. M., 1979, Non-polio enterovirus disease in the United States, 1971–1975, Int. J. Epidemiol. 8:49–54.

    PubMed  CAS  Google Scholar 

  14. Moore, M., 1982, Enteroviral disease in the United States, 1970–1979,J. Infect. Dis. 146:103–108.

    PubMed  CAS  Google Scholar 

  15. Prabhakar, B. S., Haspel, M. V., McClintock, P. R., and Notkins, A. L., 1982, High frequency of antigenic variants among naturally occurring human Coxsackie B4 virus isolates identified by monoclonal antibodies, Nature (Lond.) 300:374–376.

    CAS  Google Scholar 

  16. Prabhakar, B. S., Menegus, M. A., and Notkins, A. L., 1985. Detection of conserved and nonconserved epitopes on coxsackievirus B4: Frequency of antigenic change, Virology 146:302–306.

    PubMed  CAS  Google Scholar 

  17. Webb, S. R., Kearse, K. P., Foulke, C. L., Hartig, P. C., and Prabhakar, B. S., 1986, Neutralization epitope diversity of coxsackievirus B4 isolates detected by monoclonal antibodies,J. Med. Virol. 20:9–15.

    PubMed  CAS  Google Scholar 

  18. Ash, P., Leong, W. A., Kennett, M. L., and Schnagl, R. D., 1985, Neutralization kinetic analysis of echovirus-30 and coxsackievirus-B4 strains revealed little antigenic variation amongst the echovirus strains, Aust. J. Exp. Biol. Med. Sci. 63:219–222.

    PubMed  Google Scholar 

  19. Nottay, B. K., Kew, O. M., Hatch, M. H., Heyward, J. T., and Obijeski, J. F., 1981, Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans, Virology 108:405–423.

    PubMed  CAS  Google Scholar 

  20. Minor, P. D., 1982, Characterization of strains of type 3 poliovirus by oligonucleotide mapping,J. Gen. Virol. 59:307–317.

    PubMed  CAS  Google Scholar 

  21. Kew, O. M., and Nottay, B. K., 1984, Molecular epidemiology of polioviruses, Rev. Infect. Dis. 6:S499–S504.

    PubMed  Google Scholar 

  22. Harris, T. J. R., Doel, T. R., and Brown, F., 1977, Molecular aspects of the antigenic variation of swine vesicular disease and Coxsackie B5 viruses, J. Gen. Virol. 35:299–315.

    PubMed  CAS  Google Scholar 

  23. Cao, Y., Schnurr, D. P., and Schmidt, N.J., 1984, Monoclonal antibodies for study of antigenic variation in coxsackievirus type B4—Association of antigenic determinants with myocarditic properties of the virus,J. Gen. Virol. 65:925–932.

    PubMed  Google Scholar 

  24. Cao, Y., Schnurr, D. P., and Schmidt, N.J., 1984, Differing cardiotropic and myocarditic properties of group B type 4 coxsackievirus strains, Arch. Virol. 80:119–130.

    PubMed  CAS  Google Scholar 

  25. Jordan, G. W., Bolton, V., and Schmidt, N.J., 1985, Diabetogenic potential of Coxsackie B viruses in nature, Arch. Virol. 86:213–221.

    PubMed  CAS  Google Scholar 

  26. Jimes, S., and Jamison, R. M., 1983, Coxsackievirus B4: In vitro genetic markers and virulence, Arch. Virol. 77:1–11.

    PubMed  CAS  Google Scholar 

  27. Jimes, S., Jamison, R. M., and Grafton, W. D., 1984, Coxsackievirus B4: In vitro genetic markers and cardiovirulence, Arch. Virol. 81:345–352.

    PubMed  CAS  Google Scholar 

  28. Jordan, G. W., and Bolton, V., 1985, Interferon-sensitive coxsackievirus variants in nature,J. Interferon Res. 5:289–296.

    PubMed  CAS  Google Scholar 

  29. Hartig, P. C., and Webb, S. R., 1983, Heterogeneity of a human isolate of Coxsackie B4: Biological differences,J. Infection. 6:43–48.

    CAS  Google Scholar 

  30. Hartig, P. C., Madge, G. E., and Webb, S. R., 1983, Diversity within a human isolate of Coxsackie B4: Relationship to viral-induced diabetes,J. Med. Virol. 11:23–30.

    PubMed  CAS  Google Scholar 

  31. Danes, L., and Jaresova, I., 1985, Neutralization microtest with human coxsackievirus and echovirus serotypes, J. Hyg. Epidemiol. Microbiol. Immunol. 29:399–408.

    CAS  Google Scholar 

  32. Manjunath, N., Balaya, S., and Seth, P., 1982, Serologic survey for neutralizing antibodies against group B coxsackieviruses in normal population in Delhi area, Indian J. Med. Res. 76:656–661.

    PubMed  CAS  Google Scholar 

  33. Mukundan, P., and John, T. J., 1983, Prevalence and titres of neutralizing antibodies to group B coxsackieviruses, Indian J. Med. Res. 77:577–589.

    PubMed  CAS  Google Scholar 

  34. Santhanam, S., and Choudhury, D. S., 1984, Antibodies against Coxsackie B2 virus in infants and children in Delhi,J. Commun. Dis. 16:304–306.

    PubMed  CAS  Google Scholar 

  35. Morag, A., Margalith, M., Shuval, H. I., and Fattal, B., 1984, Acquisition of antibodies to various Coxsackie and echo viruses and hepatitis A virus in agricultural communal settlements in Israel, J. Med. Virol. 14:39–48.

    PubMed  CAS  Google Scholar 

  36. Margalith, M., Fattal, B., Shuval, H. I., and Morag, A., 1986, Prevalence of antibodies to enteroviruses and varicella-zoster virus among residents and overseas volunteers at agricultural settlements in Israel,J. Med. Virol. 20:189–197.

    PubMed  CAS  Google Scholar 

  37. Lau, R. S., 1983, Coxsackie B virus infections in New Zealand patients with cardiac and non-cardiac diseases,J. Med. Virol. 11:131–137.

    PubMed  CAS  Google Scholar 

  38. Lerner, A. M., and Wilson, F. M., 1973, Virus myocardiopathy, Prog. Med. Virol. 15:63–91.

    PubMed  CAS  Google Scholar 

  39. Hallam, N. F., Eglin, R. P., Holland, P., Bell, E. J., and Squier, M. V., 1986, Fatal Coxsackie B meningoencephalitis diagnosed by serology and in-situ nucleic acid hybridization, Lancet 2:1213–1214.

    PubMed  CAS  Google Scholar 

  40. Cooper, J. B., Pratt, W. R., English, B. K., and Shearer, W. T., 1983, Coxsackievirus B3 producing fatal meningoencephalitis in a patient with X-linked agammaglobulinemia, Am. J. Dis. Child. 137:82–83.

    PubMed  CAS  Google Scholar 

  41. Estes, M. L., and Rorke, L. B., 1986, Liquefactive necrosis in Coxsackie B encephalitis, Arch. Pathol. Lab. Med. 110:1090–1092.

    PubMed  CAS  Google Scholar 

  42. Hirschman, S. Z., and Hammer, G. S., 1974, Coxsackie virus myopericarditis, Am. J. Cardiol. 34:224–232.

    PubMed  CAS  Google Scholar 

  43. Woodruff, J. F., 1980, Viral myocarditis. A review, Am. J. Pathol. 101:427–529.

    Google Scholar 

  44. Reyes, M. P., and Lerner, A. M., 1985, Coxsackievirus myocarditis—with special reference to acute and chronic effects, Prog. Cardiovasc. Dis. 27:373–394.

    PubMed  CAS  Google Scholar 

  45. Banatvala, J. E., 1983, Coxsackie B virus infections in cardiac disease, in: Recent Advances in Clinical Virology, Vol. 3 (A. P. Waterson, ed.), pp. 99–115, Churchill Livingstone, Edinburgh.

    Google Scholar 

  46. Sundar, S., Shyam, B., Gulathi, A. K., and Somani, P. N., Coxsackie—A viral carditis in eastern India, J.Assoc. Physicians India 32:501–503.

    Google Scholar 

  47. Morita, H., Kitaura, Y., Deguchi, H., Kotaka, M., Nakayama, Y., Suwa, M., Kino, M., Hirota, Y., and Kawamura, K., 1983, Pericarditis in a young adult—Clinical course and endomyocardial biopsy findings, Jpn. Circ. J. 47:1077–1083.

    PubMed  CAS  Google Scholar 

  48. Read, R. B., Ede, R. J., Morgan-Capner, P., Moscoso, G., Portmann, B., and Williams, R., 1985, Myocarditis and fulminant hepatic failure from coxsackievirus B infection, Postgrad. Med. J. 61:749–752.

    PubMed  CAS  Google Scholar 

  49. Frisk, G., Torfason, E. G., and Diderholm, H., 1984, Reverse radioimmunoassays of IgM and IgG antibodies to Coxsackie B viruses in patients with acute myopericarditis, J. Med. Virol. 14:191–200.

    PubMed  CAS  Google Scholar 

  50. Tilzey, A. J., Signy, M., and Banatvala, J. E., 1986, Persistent Coxsackie B virus specific IgM response in patients with recurrent pericarditis. (Letter.) Lancet 1:1491–1492.

    PubMed  CAS  Google Scholar 

  51. Bowles, N. E., Richardson, P. J., Olsen, E. G. J., and Archard, L. C., 1986, Detection of coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy, Lancet 1:1120–1122.

    PubMed  CAS  Google Scholar 

  52. Rotbart, H. A., Levin, M. J., and Villarreal, L. P., 1984, Use of subgenomic poliovirus DNA hybridization probes to detect the major subgroups of enteroviruses, J. Clin. Microbiol 20:1105–1108.

    PubMed  CAS  Google Scholar 

  53. Porres, E. R., Werthammer, J., Moss, N., Bernstein, J. M., and Belshe, R. B., 1985, Fatal coxsackievirus B4 infection in a neonate, South. Med. J. 78:1254–1256.

    PubMed  CAS  Google Scholar 

  54. Barson, W. J., and Reiner, C. B., 1986, Coxsackievirus B2 infection in a neonate with incontinentia pigmenti, Pediatrics 77:897–900.

    PubMed  CAS  Google Scholar 

  55. Rozkovec, A., Cambridge, G., King, M., and Hallidie-Smith, K. A., 1985, Natural history of left ventricular function in neonatal Coxsackie myocarditis, Pediatr. Cardiol. 6:151–156.

    PubMed  CAS  Google Scholar 

  56. Schurmann, W., Statz, A., Mertens, T., Gladtke, E., and Eggers, H. J., 1983, Two cases of Coxsackie B2 infection in neonates: Clinical, virological, and epidemiological aspects, Eur. J. Pediatr. 140:59–63.

    PubMed  CAS  Google Scholar 

  57. Iwasaki, T., Monma, N., Satodate, R., Kawana, R., and Kurata, T., 1985, An immunofluorescent study of generalized Coxsackie virus B3 infection in a newborn infant, Acta Pathol. Jpn. 35:741–748.

    PubMed  CAS  Google Scholar 

  58. Fisher-Hoch, S. P., Gould, J., and Latham, P., 1982, Coxsackie B virus infection associated with hypoparathyroidism in a neonate, Lancet 2:1395–1396.

    PubMed  CAS  Google Scholar 

  59. Kaplan, M. H., Klein, S. W., McPhee, J., and Harper, R. G., 1983, Group B coxsackievirus infections in infants younger than three months of age: A serious childhood illness, Rev. Infect. Dis. 5:1019–1032.

    PubMed  CAS  Google Scholar 

  60. Modlin, J. F., 1986, Perinatal echovirus infection: Insights from a literature review of 61 cases of serious infection and 16 outbreaks in nurseries, Rev. Infect. Dis. 8:918–926.

    PubMed  CAS  Google Scholar 

  61. Reyes, M. P., Zalenski, D., Smith, F., Wilson, F. M., and Lerner, A. M., 1986, Cox-sackievirus-positive cervices in women with febrile illnesses during the third trimester in pregnancy, Am. J. Obstet. Gynecol. 155:159–161.

    PubMed  CAS  Google Scholar 

  62. Barrett-Conner, E., 1985, Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence, Rev. Infect. Dis. 7:207–215.

    Google Scholar 

  63. Nihalani, K. D., Pethani, R. R., Menon, P. S., and Mehtalia, S. D., 1982, Coxsackie B4 virus causing insulin dependent diabetes mellitus, myopericarditis and encephalitis— A case report, J.Assoc. Physicians India 30:107–109.

    CAS  Google Scholar 

  64. Niklasson, B. S., Dobersen, M. J., Peters, C. J., Ennis, W. H., and Möller, E., 1985, An outbreak of coxsackievirus B infection followed by one case of diabetes mellitus, Scand.J. Infect. Dis. 17:15–18.

    PubMed  CAS  Google Scholar 

  65. Mirkovic, R. R., Varma, S. K., and Yoon, J. W., 1984, Incidence of coxsackievirus B type 4 (CB4) infections concomitant with onset of insulin-dependent diabetes mellitus,J. Med. Virol. 14:9–16.

    PubMed  CAS  Google Scholar 

  66. Asplin, C. M., Cooney, M. K., Crossley, J. R., Dornan, T. L., Raghu, P., and Palmer, J. P., 1982, Coxsackie B4 infection and islet cell antibodies three years before overt diabetes,J. Pediatr. 101:398–400.

    PubMed  CAS  Google Scholar 

  67. Champsaur, H., 1980, Diabetes and Coxsackie virus B5 infection, Lancet 1:251.

    PubMed  CAS  Google Scholar 

  68. Mertens, T., Gruneklee, D., and Eggers, H. J., 1983, Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes, Eur. J. Pediatr. 140:293–294.

    PubMed  CAS  Google Scholar 

  69. Friman, G., Fohlman, J., Frisk, G., Diderholm, H., Ewald, U., Kobbah, M., and Tuvemo, T., 1985, An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response, Acta Paediatr Scand. [Suppl] 320:14–19.

    CAS  Google Scholar 

  70. Frisk, G., Fohlman, J., Kobbah, M., Ewald, U., Tuvemo, T., Diderholm, H., and Friman, G., 1985, High frequency of coxsackie-B-virus-specific IgM in children developing type 1 diabetes during a period of high diabetes morbidity, J. Med. Virol. 17:219–227.

    PubMed  CAS  Google Scholar 

  71. Alberti, A. M., Amato, C., Candela, A., Costantino, F., Grandolfo, M. E., Lombardi, F., Novello, F., Orsini, M., and Santoro, R., 1985, Serum antibodies against Coxsackie Bl-6 viruses in type 1 diabetics, Acta Diabetol. Lat. 22:33–38.

    PubMed  CAS  Google Scholar 

  72. Palmer, J. P., Cooney, M. K., Ward, R. H., Hansen, J. A., Brodsky, J. B., Ray, C. G., Crossley, J. R., Asplin, C. M., and Williams, R. H., 1982, Reduced Coxsackie antibody titers in type 1 (insulin-dependent) diabetic patients presenting during an outbreak of Coxsackie B3 and B4 infection, Diabetologia 22:426–429.

    PubMed  CAS  Google Scholar 

  73. King, M. L., Shaikh, A., Bidwell, D., Voller, A., and Banatvala, J. E., 1983, Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus, Lancet 1:1397–1399.

    PubMed  CAS  Google Scholar 

  74. Banatvala, J. E., Bryant, J., Schernthaner, G., Borkenstein, M., Schober, E., Brown, D., De Silva, L. M., Menser, M. A., and Silink, M., 1985, Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia, Lancet 1:1409–1412.

    PubMed  CAS  Google Scholar 

  75. Schernthaner, G., Banatvala, J. E., Scherbaum, W., Bryant, J., Borkenstein, M., Schober, E., and Mayr, W. R., 1985, Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus, Lancet 2:630–632.

    PubMed  CAS  Google Scholar 

  76. Eberhardt, M. S., Wagener, D. K., Orchard, T. J., LaPorte, R. E., Cavender, D. E., Rabin, B. S., Atchison, R. W., Kuller, L. H., Drash, A. L., and Becker, D. J., 1985, HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study, Diabetes 34:1247–1252.

    PubMed  CAS  Google Scholar 

  77. O’Neill, D., McArthur, J. D., Kennedy, J. A., and Clements, G., 1983, Coxsackie B virus infection in coronary care unit patients,J. Clin. Pathol. 36:658–661.

    PubMed  Google Scholar 

  78. Bell, E. J., Irvine, K. G., Gardiner, A. J., and Rodger, J. C., 1983, Coxsackie B infection in a general medical unit, Scott. Med. J. 28:157–159.

    PubMed  CAS  Google Scholar 

  79. Nikoskelainen, J., Kalliomaki, J. L., Lapinleimu, K., Stenvik, M., and Halonen, P. E., 1983, Coxsackie B virus antibodies in myocardial infarction, Acta Med. Scand. 214:29–32.

    PubMed  CAS  Google Scholar 

  80. Lau, R. C., 1982, Coxsackie B virus infection in acute myocardial infarction and adult heart disease, Med. J. Aust. 2:520–522.

    PubMed  CAS  Google Scholar 

  81. Lau, R. C., 1986, Coxsackie B virus-specific IgM responses in coronary care unit patients,/ Med. Virol. 18:193–198.

    CAS  Google Scholar 

  82. Hannington, G., Booth, J. C., Bowes, R. J., and Stern, H., 1986, Coxsackie B virus-specific IgM antibody and myocardial infarction,J. Med. Microbiol. 21:287–291.

    PubMed  CAS  Google Scholar 

  83. Hurst, N. P., Martynoga, A. G., Nuki, G., Sewell, J. R., Mitchell, A., and Hughes, G. R., 1983, Coxsackie B infection and arthritis, Br. Med. J. 286:605.

    CAS  Google Scholar 

  84. Heaton, D. C., and Moller, P. W., 1985, Still’s disease associated with Coxsackie infection and haemophagocytic syndrome, Ann. Rheum. Dis. 44:341–344.

    PubMed  CAS  Google Scholar 

  85. Christensen, M. L., Pachman, L. M., Schneiderman, R., Patel, D. C., and Friedman, J. M., 1986, Prevalence of Coxsackie B virus antibodies in patients with juvenile der-matomyositis, Arthńtis Rheum. 29:1365–1370.

    CAS  Google Scholar 

  86. Gauntt, C. J., Gudvangen, R. J., Brans, Y. W., and Marlin, A. E., 1985, Coxsackievirus group B antibodies in the ventricular fluid of infants with severe anatomic defects in the central nervous system, Pediatrics 76:64–68.

    PubMed  CAS  Google Scholar 

  87. Melnick, J. L., Wenner, H. A., and Phillips, C. A., 1979, Enteroviruses, in: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections (E. H. Lennette and N. J. Schmidt, eds.), pp. 471–534, American Public Health Association, Washington, D.C.

    Google Scholar 

  88. Patel, J. R., Daniel, J., Mathan, M., and Mathan, V. I., 1984, Isolation and identification of enteroviruses from faecal samples in a differentiated epithelial cell line (HRT-18) derived from human rectal carcinoma, J. Med. Virol. 14:255–261.

    CAS  Google Scholar 

  89. Patel, J. R., Daniel, J., and Mathan, V. I., 1985, A comparison of the susceptibility of three human gut tumour-derived differentiated epithelial cell lines, primary monkey kidney cells and human rhabdomyosarcoma cell line to 66-prototype strains of human enteroviruses, J.Virol. Methods 12:209–216.

    CAS  Google Scholar 

  90. Dagan, R., and Menegus, M. A., 1986, A combination of four cell types for rapid detection of enteroviruses in clinical specimens,J. Med. Virol. 19:219–228.

    PubMed  CAS  Google Scholar 

  91. Tracy, S., 1985, Comparison of genomic homologies in the coxsackievirus B group by use of cDNA: RNA dot-blot hybridization,J. Clin. Microbiol. 21:371–374.

    PubMed  CAS  Google Scholar 

  92. Tracy, S., 1984, A comparison of genomic homologies among the coxsackievirus B group: Use of fragments of the cloned coxsackievirus B3 genome as probes,J. Gen. Virol. 65:2167–2172.

    PubMed  CAS  Google Scholar 

  93. Hypiä, T., Stålhandske, P., Vainionpää, R., and Pettersson, U., 1984, Detection of enteroviruses by spot hybridization, J. Clin. Microbiol. 19:436–438.

    Google Scholar 

  94. Rotbart, H. A., Levin, M. J., Villarreal, L. P., Tracy, S. M., Semler, B. L., and Wimmer, E., 1985, Factors affecting the detection of enteroviruses in cerebrospinal fluid with coxsackievirus B3 and poliovirus 1 cDNA probes, J. Clin. Microbiol. 22:220–224.

    PubMed  CAS  Google Scholar 

  95. Dörries, R., and Ter Meulen, V., 1983, Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique, J.Gen. Virol. 64:159–167.

    Google Scholar 

  96. Morgan-Capner, P., and McSorley, C., 1983, Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM,J. Hyg. (Lond.) 90:333–349.

    CAS  Google Scholar 

  97. Hannington, G., Booth, J. C., Wiblin, C. N., and Stern, H., 1983, Indirect enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies against Coxsackie B viruses, J. Med. Microbiol. 16:459–465.

    CAS  Google Scholar 

  98. Chan, D., and Hammond, G. W., 1985, Comparison of serodiagnosis of group B Coxsackie virus infections by an immunoglobulin M capture enzvme immunoassay versus microneutralization,J. Clin. Microbiol. 21:830–834.

    PubMed  CAS  Google Scholar 

  99. McCartney, R. A., Banatvala, J. E., and Bell, E. J., 1986, Routine use of µ-antibody-capture ELISA for the serological diagnosis of Coxsackie B virus infections,J. Med. Virol. 19:205–212.

    PubMed  CAS  Google Scholar 

  100. Loh, P. C., Dow, M. A., and Fujioka, R. S., 1985, Use of the nitrocellulose-enzyme immunosorbent assay for rapid, sensitive and quantitative detection of human enteroviruses, J.Virol. Methods 12:225–234.

    CAS  Google Scholar 

  101. Tracy, S., and Latham, A., 1986, Rapid identification of Coxsackie B viruses after immunoprecipitation and nucleic acid hybridization, Diagn. Microbiol. Infect. Dis. 4:327–333.

    PubMed  CAS  Google Scholar 

  102. Pattison, J. R., 1983, Tests for Coxsackie B virus-specific IgM,J. Hyg. (Lond.) 90:327–332.

    CAS  Google Scholar 

  103. Kew, O. M., and Nottay, B. K., 1984, Evolution of the oral poliovaccine strains in humans occurs by both mutation and intramolecular recombination, in: Modern Approaches to Vaccines (R. M. Chanock and R. A. Lerner, eds.), pp. 357–367, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, U.S. Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia, 30333, USA

    Mark A. Pallansch

Authors
  1. Mark A. Pallansch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Pisa, Pisa, Italy

    Mauro Bendinelli

  2. University of South Florida, Tampa, Florida, USA

    Herman Friedman

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Pallansch, M.A. (1988). Epidemiology of Group B Coxsackieviruses. In: Bendinelli, M., Friedman, H. (eds) Coxsackieviruses. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0247-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0247-7_22

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0249-1

  • Online ISBN: 978-1-4757-0247-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation